Currently, 20-30% of patients presenting clinical features of IPEX have no mutations in FOXP3 and are termed “IPEX-like” (25). The gene discussed is FOXP3; the disease is immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.